LEAP2 is primarily secreted by the liver and increases with greater body mass and insulin resistance in individuals with prediabetes and overweight or obesity; therefore, an elevated LEAP2 level might indicate increased metabolic risk [57]. The gene discussed is LEAP2; the disease is Insulin resistance.